首站-论文投稿智能助手
典型文献
Chinese medicine in the treatment of autoimmune hepatitis: Progress and future opportunities
文献摘要:
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease occurring in indi-viduals of all ages with a higher incidence in females and characterized by hypergam-maglobulinemia, elevated serum autoantibodies and histological features of interface hepatitis. AIH pathogenesis remains obscure and still needs in- depth study, which is likely associated with genetic susceptibility and the loss of immune homeostasis. Steroids alone and in combination with other immunosuppressant agents are the pri-mary choices of AIH treatment in the clinic, whereas, in some cases, severe adverse effects and disease relapse may occur. Chinese medicine used for the treatment of AIH has proven its merits over many years and is well tolerated. To better under-stand the pathogenesis of AIH and to evaluate the efficacy of novel therapies, several animal models have been generated to recapitulate the immune microenvironment of patients with AIH. In the current review, we summarize recent advances in the study of animal models for AIH and their application in pharmacological research of Chinese medicine- based therapies and also discuss current limitations. This review aims to provide novel insights into the discovery of Chinese medicine- originated therapies for AIH using cutting- edge animal models.
文献关键词:
作者姓名:
Jia Liu;Zhi Ma;Han Li;Xiaojiaoyang Li
作者机构:
School of Life Sciences,Beijing University of Chinese Medicine,Beijing,China
引用格式:
[1]Jia Liu;Zhi Ma;Han Li;Xiaojiaoyang Li-.Chinese medicine in the treatment of autoimmune hepatitis: Progress and future opportunities)[J].动物模型与实验医学(英文),2022(02):95-107
A类:
hypergam,maglobulinemia,Steroids
B类:
Chinese,medicine,treatment,autoimmune,hepatitis,Progress,future,opportunities,Autoimmune,AIH,chronic,inflammatory,liver,disease,occurring,indi,viduals,all,ages,higher,incidence,females,characterized,by,elevated,serum,autoantibodies,histological,features,interface,pathogenesis,remains,obscure,still,needs,depth,study,which,likely,associated,genetic,susceptibility,loss,homeostasis,alone,combination,other,immunosuppressant,agents,are,pri,mary,choices,clinic,whereas,some,cases,severe,adverse,effects,relapse,may,used,has,proven,merits,many,years,well,tolerated,To,better,under,stand,evaluate,efficacy,novel,therapies,several,animal,models,have,been,generated,recapitulate,microenvironment,patients,In,current,review,summarize,recent,advances,their,application,pharmacological,research,also,discuss,limitations,This,aims,provide,insights,into,discovery,originated,using,cutting,edge
AB值:
0.624984
相似文献
Therapeutic effects of the extract of Sancao Formula,a Chinese herbal compound,on imiquimod-induced psoriasis via cysteine-rich protein 61
Wan-jun Guo;Yi Wang;Yu Deng;Lin-yan Cheng;Xin Liu;Ruo-fan Xi;Sheng-jie Zhu;Xin-yi Feng;Liang Hua;Kan Ze;Jian-yong Zhu;Dong-jie Guo;Fu-lun Li-Department of Dermatology,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China;School of Medicine,Chengdu University,Chengdu 610106,Sichuan Province,China;Institute of Cancer Biology and Drug Discovery,Chengdu University,Chengdu 610106,Sichuan Province,China;Clinical Laboratory Medicine Center,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD:A promising drug Potentilla discolor Bunge
Longshan Ji;Qian Li;Yong He;Xin Zhang;Zhenhua Zhou;Yating Gao;Miao Fang;Zhuo Yu;Robim M.Rodrigues;Yueqiu Gao;Man Li-Laboratory of Cellular Immunity,Institute of Clinical Immunology,Shanghai Key Laboratory of Traditional Chinese Medicine,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Key Laboratory of Liver and Kidney Diseases(Shanghai University of Traditional Chinese Medicine),Ministry of Education,Shanghai 201203,China;Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Hepatopathy,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of in Vitro Toxicology and Dermato-Cosmetology,Faculty of Medicine and Pharmacy,Vrije Universiteit Brussel,Brussels 1000,Belgium
Pharmacodynamic,pharmacokinetic,and phase 1a study of bisthianostat,a novel histone deacetylase inhibitor,for the treatment of relapsed or refractory multiple myeloma
Yu-bo Zhou;Yang-ming Zhang;Hong-hui Huang;Li-jing Shen;Xiao-feng Han;Xiao-bei Hu;Song-da Yu;An-hui Gao;Li Sheng;Ming-bo Su;Xiao-li Wei;Yue Zhang;Yi-fan Zhang;Zhi-wei Gao;Xiao-yan Chen;Fa-jun Nan;Jia Li;Jian Hou-National Center for New Drug Screening,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Yantai Key Laboratory of Nanomedicine&Advanced Preparations,Yantai Institute of Materia Medica,Yantai 264000,China;Department of Hematology,Renji Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200127,China;Shanghai Center for Drug Metabolism and Pharmacokinetics Research,Shanghai 201203,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。